Theratechnologies (NASDAQ:THTX) Shares Down 0.6% – What’s Next?

Theratechnologies Inc. (NASDAQ:THTX)’s stock price was down 0.6% on Friday . The stock traded as low as $1.69 and last traded at $1.72. Approximately 84,056 shares changed hands during trading, a decline of 45% from the average daily volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Trading Down 0.6 %

The stock’s 50 day moving average is $1.54 and its 200-day moving average is $1.40. The company has a market cap of $79.09 million, a P/E ratio of -17.20 and a beta of 1.30.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in Theratechnologies stock. Cyndeo Wealth Partners LLC increased its position in Theratechnologies Inc. (NASDAQ:THTX) by 26.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 131,311 shares of the company’s stock after acquiring an additional 27,191 shares during the period. Cyndeo Wealth Partners LLC owned about 0.29% of Theratechnologies worth $163,000 at the end of the most recent reporting period.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.